Manidipina Sandoz (Manidipine Dihydrochloride)

Manidipine blocks L‑type calcium channels in the smooth muscle of blood vessels. This inhibition prevents calcium‑mediated contraction, causing the vessels to relax and widen (vasodilation). The resulting drop in peripheral resistance lowers arterial pressure, providing an antihypertensive effect.

The dosage of Manidipina Sandoz is individualized by the prescribing clinician based on the patient’s blood‑pressure response, age, renal and hepatic function, and tolerability. The prescriber determines the appropriate starting dose and any subsequent adjustments.

Safety of manidipine in pregnancy and lactation has not been established. It should be avoided unless the potential benefit justifies the potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both manidipine and amlodipine belong to the calcium‑channel‑blocker class and lower blood pressure by vasodilation. Manidipine has a slightly longer half‑life and may be associated with a lower incidence of peripheral edema, while amlodipine is more widely used globally. Choice depends on clinical response, tolerability and physician preference.

Manidipina Sandoz tablets should be stored at room temperature, below 25 °C, in the original blister or bottle. Keep the product away from moisture, heat and direct sunlight to maintain stability and potency throughout its shelf life.

Manidipina Sandoz is taken orally, usually once daily. The tablet should be swallowed whole with a glass of water and can be taken with or without food. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious adverse events, although rare, include severe hypotension, hepatic injury, allergic reactions such as angio‑edema, myocardial infarction and life‑threatening arrhythmias. Patients should seek immediate medical attention if they experience symptoms like fainting, chest pain, jaundice, rash or swelling of the face and throat.

Manidipina Sandoz is contraindicated in patients with known hypersensitivity to manidipine or any excipients, in those with severe hypotension, cardiogenic shock, or unstable angina. Caution is also advised for individuals with significant hepatic impairment or severe aortic stenosis.